Clin2
NCT07389473Possibly a fitRecruiting

Studying eye movements in long-term psychiatric medication use (Gaize device)

ADHDDepression DisordersMood DisordersAnxiety Disorder GeneralizedBipolar Disorder (BPD)

Part of Mental health clinical trials.

This trial uses a special device (Gaize) to track how your eyes move while you take psychiatric medication. It aims to see how long-term medication affects eye patterns, which could help doctors better understand treatment responses.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years to 65 years
Study type
Observational

Who can take part

  • Be between 18 and 65 years old
  • Have normal or corrected vision (with glasses, contacts, or surgery)
  • Be taking a psychiatric medication as prescribed for more than 3 months
  • Not have any severe eye conditions, head injury, or photosensitive epilepsy
  • Not be pregnant, and not prone to severe motion sickness in VR

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05476523Recruiting
Eye-tracking tests for adults to study vision and brain signals

This trial uses an eye-tracking camera or software to measure how your eyes move while you do simple tasks. It’s meant to test whether the eye-tracking system can reliably collect useful movement data in people like you.

Wilmington, Delaware
NCT00286637Recruiting
New tests to diagnose glaucoma and related eye problems

This study tests new ways to diagnose glaucoma (and sometimes related eye conditions) using eye exams and measurements. It may help improve how doctors detect glaucoma earlier and more accurately.

Philadelphia, Pennsylvania
NCT06532604Not yet recruiting
Eye response study for new antidepressant treatment

This study looks at how your eyes respond to light (electrophysiological markers) to better understand how antidepressants work. If you join, your brain and eye activity will be measured before and after starting a new antidepressant, which may help doctors choose more effective treatments for depression in the future.

Laxou, Nancy
NCT03829787Recruiting
Study of attention and reward signals in bipolar disorder

This study looks at how people with bipolar disorder pay attention and respond to rewards, including whether anxiety or substance use is also present. It uses eye-tracking and related tests to better understand brain patterns that may affect mood and decision-making.

Cleveland, Ohio
NCT07858214Enrolling by invitation
Measuring eye tremors with a new device

This study tests a new device that measures tiny, natural eye movements (tremors) to see if it works well in a diverse group of people. It may help with future diagnosis and monitoring of certain health conditions.

Atlanta, Georgia
NCT05061953Recruiting
Eye-tracking test software study in adults with multiple sclerosis

This study checks how well new eye-tracking software can measure eye movements in people with multiple sclerosis. It may help researchers track changes in how the nervous system works using a simple camera-based eye test.

Montreal, Quebec

Hear when a new Depression Disorders trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.